Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer - sprookjes - yvandenbroek - TriplyDB

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer

http://www.wikidata.org/entity/Q24650026

about

Dinosaurs and ancient civilizations: reflections on the treatment of cancer Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells αV integrins in angiogenesis and cancer Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells Integrins in cancer: biological implications and therapeutic opportunities Neoplasia: the second decade.Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.Hypoxia, inflammation, and the tumor microenvironment in metastatic disease Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3 Targeted gene silencing using RGD-labeled chitosan nanoparticles.Stem cell pathways contribute to clinical chemoresistance in ovarian cancer The potential of nanomedicine therapies to treat neovascular disease in the retina.Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand Integrin inhibitors as a therapeutic agent for ovarian cancer Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.Smoothened antagonists reverse taxane resistance in ovarian cancer.Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.The War on Cancer rages on.Outside-in integrin signalling regulates haematopoietic stem cell function via Periostin-Itgav axis.Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model.Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer.Liposomes targeting tumour stromal cells.Targeting integrins in hepatocellular carcinoma.Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.RGD-mediated delivery of small-molecule drugs.The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

P2860

Q24628746-3B028413-0712-4618-8312-48D7619E0AE3 Q26738643-84FB0CB2-D571-4F24-B4CF-B3D76CDAA1E8 Q26851768-A3E84395-2136-4335-BE8D-D8371DBFBC7C Q28483911-F438F18C-BA4C-4DAA-803C-D08EDFADE6CA Q29614536-2760A220-AF08-4F16-AF73-5E186E85990D Q30484000-5E140730-15C7-475D-8BB2-BF66CCCE8978 Q30640795-EC7B4E07-DFB0-4198-A7D9-7A6A7CFFCDF6 Q33576030-2B8C8D58-67F8-4031-8E88-4D0E66194C74 Q33648443-E4489043-9B24-44D5-9499-A0B0594129B8 Q33685302-10230668-1094-44CD-A702-1FACF451B521 Q34031859-78D18491-DB78-4E7D-AF64-0F4417F88E44 Q34092005-6AC699AB-D824-4541-85BA-BFC89A360320 Q34220590-FC120570-7035-42F1-906D-E05DFE9F7E80 Q34355442-DC2EC429-C7CE-40B7-9A06-04319D27CBA4 Q34433546-3B857AB8-A39B-4206-987A-AF1EEF0C6659 Q34674722-DAC9D033-0D4F-49A7-A8A2-7220EDC87615 Q35085202-504B0F6B-B3B9-4A55-95AB-1E4E95FC6254 Q35374753-86EFE8EE-5FF6-4017-AEE9-F4C4D689ABAD Q35652998-1149DEE3-A73C-45F4-AC02-6E2AB20A9855 Q35660004-D82A98AF-0472-4A43-810D-F496C95D6AFC Q35668911-235D15CC-3796-4443-A400-BC814D1B3F95 Q36084215-46958A72-003C-42C0-B2D4-9C6D94CB6EDA Q36088158-22705364-ABCF-41D0-A7A6-37A0774D17DA Q36104744-ACE2D7BE-DFE6-4A13-BA40-9FF494A2B427 Q36544657-35295F8A-8279-470F-AB6E-BC10ABEE3505 Q36836804-0B84A127-7C99-485F-8B4D-83E84F6C6E39 Q37478602-808FD790-3AC7-4D7C-930B-0F5F6D2C40CE Q37486934-DF77559A-D00B-4694-81F5-3B57CDD4E33E Q37604850-63ADB22B-B323-4EDC-B7D6-053EE7762CC3 Q37717741-9DD4A668-60D0-404A-BBEA-406A6A939ADB Q37799613-E642925B-F5F9-432C-979B-3265949F57DD Q37844564-118E2445-2CA8-4D2F-ABCE-CE0B92690288 Q38209789-5A911F2E-7618-460D-BAF0-DEED08EAAA1F Q38399145-DC8A62A4-85CE-4D32-AAE1-CFD6C49B1690 Q38501776-6718416E-1FE5-4565-8B46-939A03FF19A4 Q38732486-174FAD21-860F-437E-A941-74D7E99C90FC Q38854040-785EB25D-686B-492A-964C-B328C9950C3D Q39047828-93229C2D-FCAB-4441-8CED-261BAB41F72A Q39429469-1B808859-94CA-46FA-9BB3-C39CDC45456A Q39720176-3498E545-00A1-4961-91C7-CF7908877C1B

P2860

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer

http://www.wikidata.org/entity/Q24650026

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@ast

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@en

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@nl

type

label

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@ast

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@en

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@nl

prefLabel

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@ast

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@en

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@nl

P1433

Q24650026-FE4FA65D-F4FF-4B66-9D3B-EBDEAEC2C652

P1476

Q24650026-94C25610-ED70-420B-BB90-C55EC821D68F

P2093

Q24650026-0B39C9B0-0E74-4B98-B8BA-F7CA37D838EB

Q24650026-1AD7EFB6-47F7-4BD0-BA54-EB2D61118816

Q24650026-2330C508-E9AC-4735-9FCA-6101623AB0A2

Q24650026-25158D05-7D29-4BF0-8B08-956E50F5A61C

Q24650026-4FECEC8B-9D18-4234-8EE9-C0AD3EC69E00

Q24650026-7CEC0FFC-7466-4835-9266-71E2DC2681B1

Q24650026-84BFEB7C-6698-4EEF-96C0-F2B928E61D5C

Q24650026-AFBC9B8C-0FEB-41C4-AE31-499D02FAB17D

Q24650026-B04D3AFE-C06F-4E03-ADE8-AF9F5C5137B9

Q24650026-DB5A7937-175F-4134-BED9-7AFFD97166BF

P2860

Q24650026-0085A796-CE04-4415-A291-F42DCFF87D04

Q24650026-0090BDE0-EF7F-45C8-B3AD-6A7DC893A94A

Q24650026-139E4AF5-B852-445E-A025-EA4A295DA02E

Q24650026-143E3C25-5839-4AE6-921F-25EF8CB174AB

Q24650026-1B42F4B8-25AC-4057-8E9B-65447F40B507

Q24650026-1B4A242C-FFF9-47B8-8BCF-8CC0FE45B4A7

Q24650026-2A40F271-3322-4095-A722-2E0BABB2E42A

Q24650026-2FA80789-FFD7-4B55-BCA1-51DE979D5EF3

Q24650026-334830E4-33CC-435E-839A-85D54C9F8957

Q24650026-33A410D0-CA45-4EE5-81F6-370C4B890AAA

P304

Q24650026-79AEA178-245D-45C0-98C0-5E69C7105794

P31

Q24650026-1C986139-B3F0-45F1-9DD0-89718C0F399E

P3181

Q24650026-0FEAEF38-5CDF-410C-811E-FC802C74FE24

P356

Q24650026-48FC8C66-328A-426E-9D9C-FB56081DCFD3

P407

Q24650026-A5493EA2-6DFA-466A-BBBB-4EEFBF5B2D5F

P433

Q24650026-D857281B-BDF5-4012-9A17-0706C0383C58

P478

Q24650026-E6D976D7-634C-47DB-BBE7-CDE7A7301CF6

P50

Q24650026-AC8B58C5-F116-4B86-A234-AB15E1747561

P577

Q24650026-90E268A2-2023-4120-B013-9BD5ACFD624B

P5875

Q24650026-15627C5A-30FD-45D2-986A-C084FCB02FE0

P698

Q24650026-1E832DD0-1DEC-4E7A-80A9-2C25E2B23F65

P921

Q24650026-AD462198-2DBE-4F74-968F-1168AEAF9EFC

Q24650026-DF11A35C-A77D-4425-B93B-192929F280B6

P932

Q24650026-9F91388B-5EDD-4BFE-A4DE-57BF6E24C15D

P3181

P356

P1433

P1476

Tumor-selective response to an ...... ta3 integrin in ovarian cancer

@en

P2093

Alpa M Nick

http://www.w3.org/2001/XMLSchema#string

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Aparna A Kamat

http://www.w3.org/2001/XMLSchema#string

Charles N Landen

http://www.w3.org/2001/XMLSchema#string

David Tice

http://www.w3.org/2001/XMLSchema#string

Liz Y Han

http://www.w3.org/2001/XMLSchema#string

Nicholas B Jennnings

http://www.w3.org/2001/XMLSchema#string

Tae-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Whitney A Spannuth

http://www.w3.org/2001/XMLSchema#string

William M Merritt

http://www.w3.org/2001/XMLSchema#string

P2860

Integrin signaling

The alpha v beta 3 integrin "vitronectin receptor"

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin

Angiogenesis in cancer, vascular, rheumatoid and other disease

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.

Integrins in vascular development.

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

Integrin signaling and matrix assembly.

P304

1259-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3935647

http://www.w3.org/2001/XMLSchema#string

P356

10.1593/NEO.08740

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Kinch

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

252709666

http://www.w3.org/2001/XMLSchema#string

P698

18953435

http://www.w3.org/2001/XMLSchema#string

P921

P932

2570602

http://www.w3.org/2001/XMLSchema#string